product

OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond

Short Description:


Product Detail

Related Video

Feedback (2)

"Control the quality by the details, show the power by quality". Our enterprise has strived to establish a remarkably efficient and stable team team and explored an effective excellent control system for Enrofloxacin Injection For Cattle , Tylosin Tartrate Injection , 1% Ivermectin Injection , We Sincerely welcome clients from all around the entire world to visit us, with our multifaceted cooperation and get the job done with each other to develop new markets, build win-win outstanding future.
OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond Detail:

Composition

Each ml contains:

Dexamethasone sodium phosphate 2 mg.

Excipients up to 1 ml.

Descriptions

Colorless clear liquid.

Pharmacological action

The drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid receptor complex. This structural change allows it`s migration in to the nucleus and then binding to specific sites on the DNA which leads to transcription of specific m-RNA and which ultimately regulates protein synthesis. It exerts highly selective glucocorticoid action. It stimulates the enzymes needed to decrease the inflammatory response.

Indications

Metabolic disorders, non-infectious inflammatory processes, especially acute musculoskeletal inflammations, allergic conditions, stress and shock conditions. As an aid in infectious diseases. Induction of parturition in ruminants during the last stage of pregnancy.

Dosage and administration

For intravenous or intramuscular injection.

Cattle : 5-20mg (2.5-10ml) per time.

Horses: 2.5-5mg (1.25-2.5ml) per time.

Cats : 0.125-0.5mg (0.0625-0.25ml) per time.

Dogs: 0.25-1mg (0.125-0.5ml) per time.

Side effect and contraindication

Except for emergency therapy, do not use in animals with chronic nephritis and hyper-corticalism (Cushing’s Syndrome). Existence of congestive heart failure, diabetes, and osteoporosis are relative contraindications. Do not use in viral infections during the viremic stage.

Caution

Care should be taken to avoid accidental self-injection.

Once vial has been broached, contents must be used within 28 days.

Dispose of any unused product and empty containers.

Wash hand after use.

Withdrawal Period

Meat: 21 days.

Milk: 72 hours.

Storage

Store in a cool and dry place below 30℃.

 


Product detail pictures:

OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond detail pictures

OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond detail pictures

OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond detail pictures


Related Product Guide:

Sticking to your belief of "Creating solutions of high quality and generating buddies with people from all around the world", we always put the fascination of customers to start with for OEM/ODM Manufacturer Dexamethasone Injectable Solution - Dexamethasone Injection – Depond , The product will supply to all over the world, such as: Hongkong, Barbados, Finland, Hard work to keep making progress, innovation in the industry, make every effort to first-class enterprise. We try our best to build the scientific management model, to learn abundant professional knowledge, to develop advanced production equipment and production process , to create the first-call quality products, reasonable price , high quality of service , quick delivery , to give you create new value .
  • This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Kama from Denmark - 2018.05.13 17:00
    This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
    5 Stars By Lydia from Suriname - 2018.07.12 12:19
    Write your message here and send it to us